Description: Management service organizations (MSOs) in value-based care have expanded into far more locations in the health care ecosystem; some demonstrate value to both buyers and providers. Explore the role of these players in the health care ecosystem, their future outlook, and how actuaries can help them perform.

Description: Due to competitive pressures, resource constraints, and the evolving availability of new evidence-based underwriting tools, many direct writing insurers are struggling with how to evaluate new data sources and incorporate them into their underwriting workflow to create an efficient accelerated underwriting program. Explore the results of a recent Individual Life AU Survey, where development was guided by a steering committee of direct writing companies. Learn more about trends that were identified through the study, including a focus on increased throughput, post-implementation monitoring, and minimization of mortality slippage.

Description: The key to influencing others is cultivating strong relationships. While maintaining authenticity, mutual respect and integrity, it is worthwhile to develop contacts, associations and affiliations that benefit your work, organization and career growth. Explore how to create influential relationships with three different entities, including your direct reports, peer group and boss. Learn how other leaders have used influencing skills to gain success and improve their organizations.

Description: Robert Eaton, FSA MAAA Principal at Milliman and Long Term Care expert will explain the basics of long term care insurance including its origins, evolution, and key components. Robert is an expert in his field and author of the textbook Insuring Long-Term Care. The video highlights the critical role of LTCI in assisting individuals with daily activities when their health deteriorates due to factors such as aging, injuries, or cognitive diseases. Contributors: Robert Eaton, FSA MAAA Danica Turner, FSA, MAAA, CERA, Scott Allen, FSA MAAA Jon Forster, ASA MAAA

Description: Health care continues to move from a fee-for-service model to a value-based care model. Hear from our expert panel on how actuaries can play a key role in the design and contracting of value-based agreements, monitoring experience and driving results, as well as measurement of value. The discussion will cover different structures currently in use, types of services covered (total cost of care, claim service lines, specialties, condition based, pharmacy products, etc), as well as nuances by market (Medicare FFS, MA, Commercial, Medicaid). The panel will discuss latest innovations in the value-based care space, as well as how COVID-19 has impacted these contracts. This interactive session will also allow you to ask your questions to our diverse group of panelists.

Description: Arun Paul, FSA MAAA Pricing Actuary for Canada Life Re-Insurance discusses morbidity as it relates to Long-Term Care Insurance. Arun is the current President of SANA The South Asian Network of Actuaries and has over a decade worth of actuarial experience. He provides insights into how morbidity is defined in Long-Term Care insurance and explains the process of filing and processing claims in this engaging discussion with Jon Forster, ASA MAAA Professional Development Learning and Content Design Director at the Society of Actuaries. They also touch upon key factors affecting Long-Term Care insurance costs, such as care duration, benefits administration, and the impact of geographic location and prior claim history on claim costs. Contributors: ARun Paul FSA MAAA, Julite Spector, FSA, MAAA Matt Morton FSA MAAA, RAchael Marsiglio FSA MAAA , Jon Forster ASA MAAA

Description: Come discuss how reinsurers can work side by side with insurer to better develop products, and lift in the areas that reinsurers have more experience, help matching products with distributions (or vice versa) and provide advanced technologies associated with tools and software. The speakers will also present Direct to Consumer plan from various points of view, i.e., distributors, carriers, and reinsurers. Some case studies will also be presented where traditional reinsurers and asset-intensive reinsurers helped insurers bring products to life.

Description: Medical pharmacy is a rapidly evolving, innovative part of healthcare in the United States that includes Oncology, Gene, and Rare disease therapies. Over the past few years, cost and utilization trends have been disrupted by biosimilars, innovative therapies, site of care options, and the COVID-19 pandemic. This volatility can make assumption setting difficult, so take a deep dive into quantifying these impacts on the drug landscape. Gain an understanding of the significance of managing site of care. Learn through adjusted time-series forecasting where medical pharmacy drug spend is expected to grow with new drugs in the pipeline. Walk away with a better understanding of the market forces and care practices that drive trend, and how medical pharmacy is expected to change in the coming years.

Description: Insurance carriers are continually challenging to innovate and evolve emerging underwriting toolswisely. A growing number of new tools continue to emerge. Uncover insights and gaina technical understanding on two models from validation studies recently conducted. Find out more information on ways to evaluate models for bias an fairness. Perspectives will be shared from both a direct carrier and reinsurance standpoint. By attending the session, you will: Gain more insight into emerging underwriting tools and methods to evaluate them.

Description: Explore a general overview of the Medicare Advantage VBID hospice model, including program goal and a brief review of available information on plan participation in 2021 and 2022. Join us to learn how the program can support other elements related to health equity and address social determinants of health. You will be able to focus on how to improve quality of life and care using palliative, concurrent and/or transitional care and hospice services. Elevate your understanding with a summary of publicly available hospice experience data published by CMS, as well as a review of published research by the SOA and others related to hospice and end of life care. Finally, expect technical guidance regarding VBID model financial implications and proposed enhancements to the program as CMS transitions from the current model due to expire at end of 2024.